Search Results 351-360 of 17183 for egfr

1. People with kidney disease should be cautious with supplements, Mayo researchers say

   Many Americans decide to take supplements on their own, not because of a doctor's recommendation, the researchers found, most often with the goal of improving ...

2. Study of ALXN2220 Versus Placebo in Adults With ATTR-CM - Mayo Clinic

   * Renal failure requiring dialysis or an eGFR \< 20 mL/min/1.73 m2 at Screening * Polyneuropathy with PND score IV. Note: Other protocol defined Inclusion ...

3. A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   ... EGFR-targeted antibody therapy is allowed regardless of the prior treatment settings. For Phase II, Arms 1 and 2, prior cetuximab or other EGFR-targeted ...

4. Study to Evaluate the Effectiveness and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy - Mayo Clinic

   eGFR ≥45 mL/min per 1.73 m2 and ≤90 mL/min per 1.73 m2 using the Chronic Kidney Diseae Epidemiology Collaboration (CKD-EPI) formula. Willing and able to ...

5. Short Bowel Syndrome and Teduglutide VS Placebo - Mayo Clinic

   Primary renal impairment (estimated GFR [eGFR] <30 ml/min). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

6. A Study of Deep Phenotyping in Patients With ALS - Mayo Clinic

   Subjects with acute kidney injury or renal insufficiency (eGFR of <20 ml/min/1.73 m^2) as they are at increased risk of Nephrogenic Systemic Fibrosis following ...

7. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

8. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 according to the Modification of Diet in Renal Disease equation. Evidence of significant ...

9. A Study of Sporadic Angiomyolipomas Growth Kinetics While on Everolimus - Mayo Clinic

   Renal Function epidermal growth factor receptor (eGFR) ≥ 30 mL/min via calculated creatinine clearance; Fasting serum cholesterol ≤ 300 mg/dL OR ≤ 7.75 ...

10. A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy - Mayo Clinic

    renal impairment (eGFR ≥ 30 ml/min/1.73m^2 to 45 30 ml/min/1.73m^2); or; any other comorbidity (to be documented in the CRF) that the physician judges to be ...